HSIC — Henry Schein stock price and chart

HSIC

Henry ScheinStock · HealthcareS&P 500 Equal Weight 0.2% · Nasdaq Composite 0.02% · S&P 500 0.01% · Russell 1000 0.01% · Russell 3000 0.01% · US Stock Market 0.01%

$84.84-0.24%

as of market close, Sep 18, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeS

20162019202120242026

45.050.055.060.065.070.075.080.085.090.0020.0M$84.84

2026-09-18

Price$84.84

MA20$81.94

MA50$75.98

Vol7.4M

What would $1,000 invested in HSIC be worth today? →

HSIC returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $84.84
Change YTD: +12.25%
Next earnings: Nov 3, 2026
Market cap: 9.5B2016-09 10.3B2026-09 9.5B-8.1% over the window
Enterprise value: 13.6B
Shares outstanding: 111.4M2016-06 163.6M2026-06 111.4M-31.9% over the window
52W low: $61.95
52W high: $92.18
From 52W high: -7.96%
From 52W low: +36.95%
52W range: 76%
Beta: 0.80

Volume

Rel volume: 2.17×
30D volume: 1M
30D $ vol: 89.8M

Fundamentals

Sales (ttm): 13.6B2016-06 11.1B2026-06 13.6B+22.3% over the window
Sales/share: $122.052016-06 $67.992026-06 $122.05+79.5% over the window
EPS (ttm): $3.432016-06 $2.962026-06 $3.43+15.9% over the window
FCF (ttm): 569M2016-12 572.4M2026-06 569M-0.6% over the window
FCF/share: $5.112016-12 $3.612026-06 $5.11+41.3% over the window
Book value/share: $28.332016-06 $18.022026-06 $28.33+57.2% over the window
Net margin: 2.96%2016-06 4.4%2026-06 3.0%-33.0% over the window
ROE: 12.77%2016-06 16.7%2026-06 12.8%-23.4% over the window
ROA: 3.54%2016-06 7.4%2026-06 3.5%-52.2% over the window
Debt / equity: 0.73×2016-06 0.242026-06 0.73+206.8% over the window
Current ratio: 1.322016-06 1.722026-06 1.32-23.1% over the window

Growth (CAGR, ttm) · 10Y

Sales: +6.51%2025-06-28 → 2026-06-2712.8B → 13.6B (+6.5% total)+2.60%2023-07-01 → 2026-06-2712.6B → 13.6B (+8.0% total)+2.71%2021-06-26 → 2026-06-2711.9B → 13.6B (+14.3% total)+2.03%2016-06-25 → 2026-06-2711.1B → 13.6B (+22.3% total)
Net income: +3.61%2025-06-28 → 2026-06-27389M → 403M (+3.6% total)-4.19%2023-07-01 → 2026-06-27458M → 403M (-12.0% total)-7.85%2021-06-26 → 2026-06-27606.5M → 403M (-33.6% total)-1.97%2016-06-25 → 2026-06-27491.5M → 403M (-18.0% total)
FCF: +50.34%2025-06-28 → 2026-06-27379M → 569M (+50.1% total)+2.27%2023-07-01 → 2026-06-27532M → 569M (+7.0% total)-6.18%2021-06-26 → 2026-06-27782.9M → 569M (-27.3% total)+0.43%2015-12-26 → 2026-06-27543.8M → 569M (+4.6% total)
Shares: -8.13%2025-06-28 → 2026-06-27121.3M → 111.4M (-8.1% total)-5.16%2023-07-01 → 2026-06-27130.6M → 111.4M (-14.7% total)-4.42%2021-06-26 → 2026-06-27139.7M → 111.4M (-20.2% total)-3.76%2016-06-25 → 2026-06-27163.6M → 111.4M (-31.9% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +10.32%2025-06-28 → 2026-06-27$3.11 → $3.43 (+10.3% total)+0.22%2023-07-01 → 2026-06-27$3.41 → $3.43 (+0.7% total)-4.14%2021-06-26 → 2026-06-27$4.24 → $3.43 (-19.1% total)+1.49%2016-06-25 → 2026-06-27$2.96 → $3.43 (+15.9% total)
Sales/share: +15.93%2025-06-28 → 2026-06-27$105.33 → $122.05 (+15.9% total)+8.18%2023-07-01 → 2026-06-27$96.47 → $122.05 (+26.5% total)+7.46%2021-06-26 → 2026-06-27$85.17 → $122.05 (+43.3% total)+6.02%2016-06-25 → 2026-06-27$67.99 → $122.05 (+79.5% total)
FCF/share: +63.64%2025-06-28 → 2026-06-27$3.13 → $5.11 (+63.4% total)+7.84%2023-07-01 → 2026-06-27$4.07 → $5.11 (+25.3% total)-1.85%2021-06-26 → 2026-06-27$5.60 → $5.11 (-8.9% total)+4.19%2015-12-26 → 2026-06-27$3.32 → $5.11 (+53.9% total)
Book value/share: -0.28%2025-06-28 → 2026-06-27$28.41 → $28.33 (-0.3% total)+1.29%2023-07-01 → 2026-06-27$27.26 → $28.33 (+3.9% total)+3.32%2021-06-26 → 2026-06-27$24.05 → $28.33 (+17.8% total)+4.63%2016-06-25 → 2026-06-27$18.02 → $28.33 (+57.2% total)
Price: +23.78%2025-09-18 → 2026-09-18$68.55 → $84.84 (+23.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+4.63%2023-09-18 → 2026-09-18$74.06 → $84.84 (+14.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.83%2021-09-17 → 2026-09-18$77.47 → $84.84 (+9.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+2.80%2016-09-16 → 2026-09-18$64.35 → $84.84 (+31.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +23.78%2025-09-18 → 2026-09-18$68.55 → $84.84 (+23.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+4.63%2023-09-18 → 2026-09-18$74.06 → $84.84 (+14.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.83%2021-09-17 → 2026-09-18$77.47 → $84.84 (+9.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+2.80%2016-09-16 → 2026-09-18$64.35 → $84.84 (+31.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 24.7×2016-09 20.682026-09 23.46+13.4% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 13.9×2016-09 13.572026-09 13.90+2.5% over the window
Fwd P/E: 14.3×
P/S (ttm)Market cap ÷ TTM revenue.: 0.7×2016-09 0.912026-09 0.70-23.6% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.0×2016-09 3.552026-09 2.99-15.7% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 16.6×2016-09 18.922026-09 16.62-12.2% over the window
EV/EBITDA (fy): 13.5×
EV/Sales (ttm): 1.0×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 6.02%2016-12 6.0%2026-06 6.1%+2.1% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-27) ÷ shares_at(2025-06-28) = 1 − 111.4M ÷ 121.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 8.13%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (8.13%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-28) ($8.9B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 8.13%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($728M) ÷ today's market cap ($9.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 7.70%2016-06 3.3%2026-06 7.8%+133.6% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $728M + TTM dividends $0) ÷ today's market cap ($9.5B). Same caveat as the cash buyback yield.: 7.70%2016-06 3.3%2026-06 7.8%+133.6% over the window

Vs own 10Y history

P/E: 80th
P/OI: 51st
P/S: 27th
P/B: 50th
P/FCF: 32nd

Bar = where today’s multiple sits in HSIC’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-09-18

-0.24%

-3.98%

-4.92%

+6.16%

YTD

+12.25%

+23.76%

+9.51%

Financial statements

Open full HSIC financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-5.94%	+0.04%
JNJ	Johnson & Johnson	-0.41%	-0.09%
ABBV	AbbVie Inc.	+1.95%	-0.02%
MRK	Merck & Co. Inc.	+8.66%	-0.19%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-4.32%	+0.45%
TMO	Thermo Fisher Scientific Inc.	+10.60%	-1.04%
AMGN	Amgen Inc.	-9.32%	+1.55%
GILD	Gilead Sciences Inc.	+4.65%	-0.52%

Henry Schein (HSIC) trades at $84.84 with a live price and an interactive chart covering 30+ years of daily price history, plus key valuation metrics. ChartRow also publishes HSIC’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full HSIC financial statements →

HSIC — Henry Schein price, chart and key statistics